Romano Brothers & Co’s Medtronic MDT Stock Holding History

Romano Brothers & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.92M	Buy	33,676 +203	+0.6%	+$19.4K	0.33%	89
2025 Q4	$3.22M	Sell	33,473 -650	-2%	-$63.1K	0.37%	78
2025 Q3	$3.25M	Sell	34,123 -100	-0.3%	-$9.19K	0.37%	77
2025 Q2	$2.98M	Sell	34,223 -800	-2%	-$67.8K	0.37%	77
2025 Q1	$3.15M	Sell	35,023 -1,450	-4%	-$130K	0.41%	73
2024 Q4	$2.91M	Sell	36,473 -3,070	-8%	-$266K	0.37%	82
2024 Q3	$3.56M	Sell	39,543 -1,350	-3%	-$114K	0.44%	68
2024 Q2	$3.22M	Sell	40,893 -1,335	-3%	-$109K	0.45%	66
2024 Q1	$3.68M	Sell	42,228 -4,579	-10%	-$391K	0.5%	60
2023 Q4	$3.86M	Sell	46,807 -4,866	-9%	-$371K	0.57%	48
2023 Q3	$4.05M	Sell	51,673 -2,038	-4%	-$171K	0.63%	49
2023 Q2	$4.73M	Sell	53,711 -400	-0.7%	-$34.4K	0.71%	40
2023 Q1	$4.36M	Sell	54,111 -7,792	-13%	-$635K	0.67%	44
2022 Q4	$4.81M	Sell	61,903 -6,796	-10%	-$551K	0.73%	38
2022 Q3	$5.55M	Buy	+68,699	New	+$6.17M	0.9%	26

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Romano Brothers & Co's MDT Position: Q1 2026 in Review

Romano Brothers & Co increased its Medtronic (MDT) stake by 0.61% in Q1 2026, buying an estimated $19.4K and bringing the position to 33,676 shares worth $2.92M. The position accounts for 0.33% of the portfolio, ranked #89.

Romano Brothers & Co first reported a position in MDT in Q3 2022 and has held it in 15 quarters since. The position peaked at $5.55M in Q3 2022. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Romano Brothers & Co held 33,676 shares of Medtronic worth $2.92M as of Q1 2026.
Romano Brothers & Co bought 203 Medtronic shares in Q1 2026, an estimated $19.4K.
Medtronic made up 0.33% of Romano Brothers & Co's portfolio in Q1 2026, its #89 holding.
Romano Brothers & Co first reported a position in Medtronic in Q3 2022 and has held it in 15 quarters since.
Romano Brothers & Co's Medtronic position peaked at $5.55M in Q3 2022.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Romano Brothers & Co's 13F filing for Q1 2026, filed 22 Apr 2026.